Literature DB >> 34587483

Acute Management of High-Risk and Intermediate-Risk Pulmonary Embolism in Children: A Review.

Catherine Ross1, Riten Kumar2, Marie-Claude Pelland-Marcotte3, Shivani Mehta4, Monica E Kleinman5, Ravi R Thiagarajan6, Muhammad B Ghbeis6, Christina J VanderPluym6, Kevin G Friedman7, Diego Porras8, Francis Fynn-Thompson9, Samuel Z Goldhaber10, Leonardo R Brandão11.   

Abstract

Severe forms of pulmonary embolism (PE) in children, althought rare, cause significant morbidity and mortality. We review the pathophysiologic features of severe (high-risk and intermediate-risk) PE and suggest novel pediatric-specific risk stratifications and an acute treatment algorithm to expedite emergent decision-making. We defined pediatric high-risk PE as causing cardiopulmonary arrest, sustained hypotension, or normotension with signs or symptoms of shock. Rapid primary reperfusion should be pursued with either surgical embolectomy or systemic thrombolysis in conjunction with a heparin infusion and supportive care as appropriate. We defined pediatric intermediate-risk PE as a lack of systemic hypotension or compensated shock, but with evidence of right ventricular strain by imaging, myocardial necrosis by elevated cardiac troponin levels, or both. The decision to pursue primary reperfusion in this group is complex and should be reserved for patients with more severe disease; anticoagulation alone also may be appropriate in these patients. If primary reperfusion is pursued, catheter-based therapies may be beneficial. Acute management of severe PE in children may include systemic thrombolysis, surgical embolectomy, catheter-based therapies, or anticoagulation alone and may depend on patient and institutional factors. Pediatric emergency and intensive care physicians should be familiar with the risks and benefits of each therapy to expedite care. PE response teams also may have added benefit in streamlining care during these critical events.
Copyright © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  anticoagulation; pediatric pulmonary embolism; surgical embolectomy; thrombolysis

Mesh:

Year:  2021        PMID: 34587483      PMCID: PMC8941619          DOI: 10.1016/j.chest.2021.09.019

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  74 in total

1.  Surgical pulmonary embolectomy and catheter-directed thrombolysis for treatment of submassive pulmonary embolism.

Authors:  Ahmed A Kolkailah; Sameer Hirji; Gregory Piazza; Julius I Ejiofor; Fernando Ramirez Del Val; Jiyae Lee; Siobhan McGurk; Sary F Aranki; Prem S Shekar; Tsuyoshi Kaneko
Journal:  J Card Surg       Date:  2018-04-16       Impact factor: 1.620

2.  Pulmonary embolism-experience at a single children's hospital.

Authors:  Madhvi Rajpurkar; Indira Warrier; Meera Chitlur; Cynthia Sabo; Mary Jane Frey; Wendy Hollon; Jeanne Lusher
Journal:  Thromb Res       Date:  2006-07-31       Impact factor: 3.944

3.  Pharmacokinetics and effects on fibrinolytic and coagulation parameters of two doses of recombinant tissue-type plasminogen activator in healthy volunteers.

Authors:  M Verstraete; C A Su; P Tanswell; W Feuerer; D Collen
Journal:  Thromb Haemost       Date:  1986-08-20       Impact factor: 5.249

4.  Moderate pulmonary embolism treated with thrombolysis (from the "MOPETT" Trial).

Authors:  Mohsen Sharifi; Curt Bay; Laura Skrocki; Farnoosh Rahimi; Mahshid Mehdipour
Journal:  Am J Cardiol       Date:  2012-10-24       Impact factor: 2.778

5.  Half-Dose Versus Full-Dose Alteplase for Treatment of Pulmonary Embolism.

Authors:  Tyree H Kiser; Ellen L Burnham; Brendan Clark; P Michael Ho; Richard R Allen; Marc Moss; R William Vandivier
Journal:  Crit Care Med       Date:  2018-10       Impact factor: 7.598

6.  Massive pulmonary embolism: surgical embolectomy versus thrombolytic therapy--should surgical indications be revisited?

Authors:  Thierry Aymard; Alexander Kadner; Alexandra Widmer; Reto Basciani; Hendrik Tevaearai; Alberto Weber; Jürg Schmidli; Thierry Carrel
Journal:  Eur J Cardiothorac Surg       Date:  2012-03-30       Impact factor: 4.191

Review 7.  Guideline on the investigation, management and prevention of venous thrombosis in children.

Authors:  Elizabeth Chalmers; Vijeya Ganesen; Ri Liesner; Sanjay Maroo; Timothy Nokes; D Saunders; Michael Williams
Journal:  Br J Haematol       Date:  2011-05-20       Impact factor: 6.998

Review 8.  Massive pulmonary emboli in children: does fiber-optic-guided embolectomy have a role? Review of the literature and report of two cases.

Authors:  Zeev Motti Eini; Sion Houri; Ilan Cohen; Raheli Sion; Akiva Tamir; Lior Sasson; Avigdor Mandelberg
Journal:  Chest       Date:  2013-02-01       Impact factor: 9.410

Review 9.  Thrombolysis in children.

Authors:  Michael D Williams
Journal:  Br J Haematol       Date:  2009-10-05       Impact factor: 6.998

Review 10.  Lessons from a patient with cardiac arrest due to massive pulmonary embolism as the initial presentation of Wilms tumor: a case report and literature review.

Authors:  Atsuna Fukuda; Takeshi Isoda; Naoya Sakamoto; Keisuke Nakajima; Tetsuya Ohta
Journal:  BMC Pediatr       Date:  2019-01-31       Impact factor: 2.125

View more
  2 in total

1.  Catheter-directed embolectomy for massive pulmonary embolism in a pediatric patient.

Authors:  Shin Mei Chan; Fabian M Laage Gaupp; Jessica M Lee; Jeffrey S Pollak; Akhil Khosla
Journal:  SAGE Open Med Case Rep       Date:  2022-07-12

Review 2.  Thrombolysis in Children: A Case Report and Review of the Literature.

Authors:  Gary M Woods; Dennis W Kim; Matthew L Paden; Heather K Viamonte
Journal:  Front Pediatr       Date:  2022-01-24       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.